{"id":"https://openalex.org/W2481123790","doi":"https://doi.org/10.1182/blood.v106.11.639.639","title":"GRN163L, a Novel and Potent Telomerase Inhibitor, Inhibits Myeloma Cell Growth In Vitro and In Vivo.","display_name":"GRN163L, a Novel and Potent Telomerase Inhibitor, Inhibits Myeloma Cell Growth In Vitro and In Vivo.","publication_year":2005,"publication_date":"2005-11-16","ids":{"openalex":"https://openalex.org/W2481123790","doi":"https://doi.org/10.1182/blood.v106.11.639.639","mag":"2481123790"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v106.11.639.639","doi":"https://doi.org/10.1182/blood.v106.11.639.639","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v106.11.639.639","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["Medicine, Harvard Medical School, Boston, MA, USA","Research and Development, VA Boston Health Care System, West Roxbury, MA, USA","The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Research and Development, VA Boston Health Care System, West Roxbury, MA, USA","institution_ids":["https://openalex.org/I2801671727"]},{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070409772","display_name":"Hemanta Koley","orcid":"https://orcid.org/0000-0003-1379-9563","observed_orcids":["https://orcid.org/0000-0003-1379-9563"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hemanta Koley","raw_affiliation_strings":["Medicine, Harvard Medical School, Boston, MA, USA","Research and Development, VA Boston Health Care System, West Roxbury, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Research and Development, VA Boston Health Care System, West Roxbury, MA, USA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077467836","display_name":"Pierfrancesco Tassone","orcid":"https://orcid.org/0000-0002-8298-6787","observed_orcids":["https://orcid.org/0000-0002-8298-6787"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pierfrancesco Tassone","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112900180","display_name":"Paola Neri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paola Neri","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007863504","display_name":"Alexei I. Protopopov","orcid":"https://orcid.org/0000-0002-3156-1279","observed_orcids":["https://orcid.org/0000-0002-3156-1279"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexei Protopopov","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011251007","display_name":"Sergei M Gryaznov","orcid":"https://orcid.org/0009-0004-4743-8592","observed_orcids":["https://orcid.org/0009-0004-4743-8592"]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergei Gryaznov","raw_affiliation_strings":["Preclinical Development, Geron Corporation, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Development, Geron Corporation, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111899982","display_name":"Allison C. Chin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Chin","raw_affiliation_strings":["Preclinical Development, Geron Corporation, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Development, Geron Corporation, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072974193","display_name":"Robert C. Bertheau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert C. Bertheau","raw_affiliation_strings":["Medicine, Harvard Medical School, Boston, MA, USA","Research and Development, VA Boston Health Care System, West Roxbury, MA, USA","The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Research and Development, VA Boston Health Care System, West Roxbury, MA, USA","institution_ids":["https://openalex.org/I2801671727"]},{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012712111","display_name":"Constantine S. Mitsiades","orcid":"https://orcid.org/0000-0003-2321-8005","observed_orcids":["https://orcid.org/0000-0003-2321-8005"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constantine Mitsiades","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Medicine, Harvard Medical School, Boston, MA, USA","The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Medicine, Harvard Medical School, Boston, MA, USA","Research and Development, VA Boston Health Care System, West Roxbury, MA, USA","The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Research and Development, VA Boston Health Care System, West Roxbury, MA, USA","institution_ids":["https://openalex.org/I2801671727"]},{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34351883,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"106","issue":"11","first_page":"639","last_page":"639"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/grn163l","display_name":"GRN163L","score":0.9679999947547913},{"id":"https://openalex.org/keywords/telomerase-inhibitors","display_name":"telomerase inhibitors","score":0.9300000071525574},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8169999718666077},{"id":"https://openalex.org/keywords/telomere-shortening","display_name":"telomere shortening","score":0.9020000100135803},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C94581717","wikidata":"https://www.wikidata.org/wiki/Q331839","display_name":"Telomerase","level":3,"score":0.7672604322433472},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.6474839448928833},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.5892148613929749},{"id":"https://openalex.org/C177336024","wikidata":"https://www.wikidata.org/wiki/Q14872779","display_name":"Telomere","level":3,"score":0.5890964269638062},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5485294461250305},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5430088043212891},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4569249153137207},{"id":"https://openalex.org/C125593758","wikidata":"https://www.wikidata.org/wiki/Q15315135","display_name":"Telomerase reverse transcriptase","level":4,"score":0.4566284120082855},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4236436188220978},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.42027682065963745},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08174610137939453},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v106.11.639.639","doi":"https://doi.org/10.1182/blood.v106.11.639.639","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v106.11.639.639","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2539982480","https://openalex.org/W2023833929","https://openalex.org/W2280060180","https://openalex.org/W2121955345","https://openalex.org/W2343002411","https://openalex.org/W3009164101","https://openalex.org/W2979354854","https://openalex.org/W2584462138","https://openalex.org/W2247199183","https://openalex.org/W2535639568"],"abstract_inverted_index":{"Abstract":[0],"Telomerase":[1],"activity":[2,107,157,346],"is":[3,16],"either":[4],"low":[5],"or":[6,49],"completely":[7],"absent":[8],"in":[9,18,43,60,63,121,195,203,215,226,236,250,265,270,284,305,313,400,403],"most":[10,19],"normal":[11,53],"somatic":[12],"cells;":[13],"while":[14,46],"it":[15],"elevated":[17],"cancer":[20],"cells":[21,45,83,95,130,198,206,231,283,362,384],"providing":[22],"unlimited":[23],"proliferative":[24],"potential":[25],"by":[26,81,118,311],"preventing":[27],"telomere":[28,36],"shortening.":[29],"The":[30,189],"inhibitors":[31],"of":[32,66,74,89,105,128,155,252,259,268,275,280,334,336,356,383,398],"telomerase,":[33],"therefore,":[34],"induce":[35],"shortening":[37],"leading":[38],"to":[39,93,232,360,372,380],"apoptotic":[40,190],"cell":[41,123,140,164,177,191,307,353],"death":[42,141,165,178,192],"tumor":[44,306],"having":[47],"little":[48],"no":[50],"effect":[51],"on":[52,221,296,351],"diploid":[54],"cells.":[55,239],"We":[56,262,329,342],"have":[57,159,263,330,343],"evaluated":[58,332],"the":[59,71,85,285,291,392],"vitro":[61],"and":[62,97,115,125,138,144,158,173,175,181,202,318,402],"vivo":[64,266],"efficacy":[65,267,333],"thio-phosphoramidate":[67],"oligonucleotide":[68],"specifically":[69,100],"targeting":[70],"RNA":[72],"component":[73],"telomerase":[75,106,156],"(GRN163L)":[76],"with":[77,102,131,169,185,213,246,254,324,338,347,364,387,405],"demonstrated":[78],"nuclear":[79],"uptake":[80],">99%":[82],"without":[84],"transfection":[86],"enhancer.":[87],"Delivery":[88],"GRN163L":[90,132,237,241,269,293,337,365,399],"(1":[91,366],"\u03bcM)":[92,359,367],"MM":[94],"(INA6":[96],"ARP)":[98],"was":[99,116,193,211,243,294,327],"associated":[101,212,245],"complete":[103,373],"loss":[104],"as":[108,110,309],"early":[109],"6":[111],"hrs":[112],"following":[113],"exposure":[114],"accompanied":[117],"a":[119,247,271],"reduction":[120,214,249,304,312],"myeloma":[122,282,315,352,361,401],"growth":[124,279,374,382],"survival.":[126],"Treatment":[127],"INA6":[129,197,230],"for":[133,368,395],"three":[134],"weeks":[135,168,201],"induced":[136],"96\u00b14%":[137],"100%":[139,176],"at":[142,166,179,199,207],"0.5":[143,170],"1":[145],"\u03bcM":[146,171,187],"concentrations,":[147],"respectively.":[148],"ARP":[149,205],"cells,":[150],"which":[151],"express":[152],"higher":[153],"levels":[154],"longer":[160],"telomeres,":[161,256],"showed":[162],"67\u00b14%":[163],"5":[167,182],"inhibitor":[172,349],"82\u00b13%":[174],"4":[180],"weeks,":[183],"respectively,":[184],"2":[186],"GRN163L.":[188],"confirmed":[194,264],"51%":[196],"two":[200,300],">80%":[204],"four":[208,377],"weeks.":[209],"Apoptosis":[210],"mean":[216],"Telomere":[217],"Fluorescence":[218],"Intensity":[219],"(TFI)":[220],"interphase":[222],"chromosomes":[223,253],"from":[224],"87.1\u00b16.2":[225],"control":[227,325],"oligo":[228,326],"treated":[229,238],"36.2\u00b12":[233],"(2.4":[234],"fold)":[235],"Moreover,":[240],"treatment":[242],"also":[244],"similar":[248],"number":[251],"detectable":[255],"indicating":[257],"development":[258],"telomere-free":[260],"ends.":[261],"SCID-hu":[272],"murine":[273],"model":[274],"multiple":[276],"myeloma.":[277],"Following":[278],"GFP-transduced":[281],"fetal":[286],"bone":[287],"chip":[288],"introduced":[289],"into":[290],"mice,":[292],"injected":[295,323],"alternate":[297],"days.":[298],"In":[299],"independent":[301],"experiments":[302],"significant":[303],"growth,":[308],"measured":[310],"human":[314],"related":[316],"protein,":[317],"better":[319],"survival":[320],"than":[321],"mice":[322],"observed.":[328],"now":[331],"combination":[335,404],"other":[339],"novel":[340],"agents.":[341],"observed":[344],"synergistic":[345],"Hsp90":[348,406],"17AAG":[350,357],"death.":[354],"Addition":[355],"(0.05":[358],"pre-treated":[363,386],"one":[369],"week":[370],"led":[371],"arrest":[375],"within":[376],"days":[378],"compared":[379],"continued":[381],"not":[385],"GRN-163.":[388],"These":[389],"data":[390],"provide":[391],"preclinical":[393],"rationale":[394],"clinical":[396],"evaluation":[397],"inhibitor.":[407]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-08-23T00:00:00"}